Van Cutsem E, Muro K, Cunningham D, Bodoky G, et al. Biomarker analyses of second-line ramucirumab in patients with advanced gastric cancer from RAINBOW, a global, randomized, double-blind, phase 3 study. Eur J Cancer 2020;127:150-157.
PMID: 32014812